Impact of atypical antipsychotics on outcomes of care in schizophrenia.
about
Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study.Defining and assessing adherence to oral antipsychotics: a review of the literatureUse of risperidone long-acting injectable in a rural border community clinic in southern californiaAdherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia.Can adherence to antihypertensive therapy be used to promote adherence to statin therapy?
P2860
Impact of atypical antipsychotics on outcomes of care in schizophrenia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Impact of atypical antipsychotics on outcomes of care in schizophrenia.
@ast
Impact of atypical antipsychotics on outcomes of care in schizophrenia.
@en
type
label
Impact of atypical antipsychotics on outcomes of care in schizophrenia.
@ast
Impact of atypical antipsychotics on outcomes of care in schizophrenia.
@en
prefLabel
Impact of atypical antipsychotics on outcomes of care in schizophrenia.
@ast
Impact of atypical antipsychotics on outcomes of care in schizophrenia.
@en
P2093
P1476
Impact of atypical antipsychotics on outcomes of care in schizophrenia
@en
P2093
Amie T Joyce
Antony D Loebel
Daniel A Ollendorf
David J Harrison
P304
P433
P577
2005-09-01T00:00:00Z